Sabiha Essack, Professor in Pharmaceutical Sciences at the University of KwaZulu-Natal (UKZN) is the South African Research Chair in Antibiotic Resistance and One Health. Professor Essack serves as expert consultant on antimicrobial resistance (AMR) to the WHO in Geneva and the WHO Regional Office for Africa. She is founder and co-chair of the South African Chapter of the Alliance for the Prudent Use of Antibiotics (APUA), member of the FIP Working Group on Antimicrobial Resistance and chairperson of the Global Respiratory Infections Partnership (GRIP). She serves on the South African Chapter of the Global Antibiotic Resistance Partnership (GARP) and the South African Antibiotic Stewardship Programme and has just completed her term as Vice Chairperson of the Ministerial Advisory Committee on AMR in South Africa.
Dr Nonhlanhla Kalebaila is a Research Manager at the Water Research Commission, leading a portfolio of research on domestic water supply, drinking water treatment and water quality. Dr Kalebaila possesses a PhD in Chemical Technology, specialising in Water Utilisation. During the course of her academic career, she has worked in the fields of environmental science, applied science, biochemistry, microbiology, nuclear technology and water and wastewater treatment, and has authored and co-authored a number of peer reviewed research papers, including original research papers, a book chapter and conference articles.
Gunnar Skov Simonsen MD, PhD (born 1965) is Professor and Director at the Department of Microbiology and Infection Control at the University Hospital of North Norway in Tromsø, Norway. He is in charge of NORM – The Norwegian Organization for Surveillance of Antimicrobial Resistance. He has co-authored more than 80 papers in international peer-reviewed journals. Simonsen has previously served as Medical Officer at WHO HQ in Geneva (2002 – 2003). Simonsen is the Norwegian National Focal Point for AMR at the European Center for Disease Prevention and Control (ECDC) as well as member of the Coordination Group for the European Antimicrobial Resistance Surveillance Network (EARS-Net). He worked 2012-2013 at the WHO Collaborating Center for Surveillance of Antimicrobial Resistance at Brigham and Women´s Hospital / Harvard Medical School in Boston (USA). Since 2015 he has served as member of the Scientific Advisory Board of the EU Joint Programming Initiative for Antimicrobial Resistance (JPI-AMR).
Dr Garance Upham (Economist) is the Vice-President of the World Alliance Against Antibiotic Resistance (WAAAR), the largest global NGO working on antibiotic resistance. Dr Upham has vast experience in IPC training against bloodborne (HIV, Hepatitis, bacterial diseases) transmission in health care systems and prevention of airborne (TB) transmission in LMIC countries during the 1990s-2000. A member of the Stakeholders Group of the Global AMR R&D Hub as well as the Steering Committee of Patients for Patient Safety, (UK-WHO initiative) (2004-2014). She is the co-editor in chief of the yearly “AMR Control”.
Moritz van Vuuren is Emeritus Professor in Microbiology. His involvement with antimicrobial resistance (AMR) started in 1999 when he was invited to become a member of the World Organisation for Animal Health’s ad hoc committee on AMR. In 2007 he and his research team published the first national surveillance data for resistance to antimicrobial drugs in bacteria from animals in South Africa. His current activities include joint-chairmanship of the South African Antibiotic Stewardship Programme; member of the Ministerial Advisory Committee on AMR; member of the Veterinary Clinical Committee of the South African Health Products Regulatory Authority; Director of the Food Safety and Food Security Portfolio of the South African Veterinary Council, and member of the Pharmaceutical Stewardship Working Group of the World Veterinary Association.
Jay K. Varma, MD is the Senior Advisor to Africa CDC. He develops strategy and supports implementation of Africa CDC’s programs in surveillance, emergency preparedness and response, information systems, laboratory systems, and workforce development. After graduating magna cum laude with highest honors from Harvard, Dr. Varma completed medical school, internal medicine residency, and chief residency at the University of California, San Diego School of Medicine. From 2001-2017, he worked on infectious diseases prevention and control for US CDC with postings in Atlanta, Bangkok, Beijing, and New York City. Dr. Varma has authored 126 scientific manuscripts, six essays, and one book.